Phase I/II Study of TLR7 Agonist Imiquimod and Radiotherapy in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Imiquimod (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 16 Feb 2017 Planned End Date changed from 1 Sep 2018 to 1 Feb 2019.
- 16 Feb 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Feb 2018.
- 16 Feb 2017 Status changed from recruiting to active, no longer recruiting.